GHISLAINE MAXWELL-HY ACCT. For the Period 12/1/12 to 12/31/12 Type Description Quantity Amount Settle Date Selection Method Cost Interest Purchased 12/10 Accrued Int Paid ARCELORMITTAL 81/4% FEB 25 2022 DTD 02/28/2012 99.50 MORGAN STANLEY & CO. INCORPORATED TRADE DATE 11/09/12 (ID: 05938L-AX-2) 0.00 (30.00) 12/13 Accrued IM Paid AMC NETWORKS INC 7.75% JUL 15 2021 DTD 07/0912012 C 114.75 MLPFS INC/FIXED INCOME TRADE DATE 12/10/12 (ID: 00164V-AB-9) 000 (223.03) 12/14 Accrued Int Paid AMC NETWORKS INC 7.75% JUL 15 2021 DTD 07/09/2012 41 115.25 MLPFS INC/FIXED INCOME TRADE DATE 12/11/12 (ID: 00164V•AB.9) 000 (96.23) Total Interest Purchased TRADE ACTIVITY ($34926) Note: L indicates Long Term Realized Gain/Loss • Settled transaction was initiated in prior statement period and settled in current statement period Trade Date WNt 5iire Type Description Quantity Per Unit Amount Proceeds Tax Cost Realized Gain/Loss Selection Method Settled Sales/MaturitlesARedemptions 12/7 12/12 Sale High Cost SUPERVALU INC 8% MAY 01 2016 OTD 05/07/2009 95.75 GOLDMAN SACHS & CO. (D:868536 -AT-0) (1,000.000) 95.75 957.50 (1,037.50) (80.00) L 12/7 12/12 Sale High Cost SUPERVALU INC 8% MAY 01 2016 DTD 05107/2009 95.75 UBS SECURITIES LLC (ID: 868536-AT4J) (1,000.000) 95.75 957.50 (1.037.50) (80.00) L 12/7 12/12 Sale High Cost SUPERVALU INC 8% MAY01 2016 DTD 05/07/2009 95.75 MORGAN STANLEY & CO. INCORPORATED (ID: 868536-AT-0) (2.000.000) 95.75 1,915.00 (2.075.00) (160.00) 12/7 12/12 Sale High Cost SUPERVALU INC 8% MAY 01 2016 DTD 05/07/2009 C 96.75 MLPFS INC/FIXED INCOME (ID: 888536-AT-0) (1,000.000) 9575 957.50 (1,037.50) (80.00 JP Morgan Page 24 of 26 Confidential Treatment Requested by JPMorgan Chase CONFIDENTIAL JPM-SDNY-00050593 SDNY_GM_00319791 EFTA01522996